Intra Cellular Therapies



Ebit Veränderung Datum
Acadia Pharmaceuticals USD 19.29M 12.3M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Biogen USD 582.8M 61.3M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Cytokinetics USD -155631000 16.59M 2025-03
Gilead Sciences USD 2.89B 221M 2025-03
Halozyme Therapeutics USD 182.75M 19.56M 2024-12
J&J USD 7.39B 2.04B 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Prothena USD -64897000 1.62M 2024-12
RedHill Biopharma USD 2.69M 47.97M 2023-06
Supernus Pharmaceuticals USD 48.3M 19.4M 2024-12
United Therapeutics USD 382.8M 25.1M 2025-03



Intra Cellular Therapies - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.